Today’s Stock Market in 2-Minutes
September 11, 2026
-
-
The $900 Billion Data Center Boom Is Just Getting Started
September 11, 2026
-
Polymath and High Ridge Trust Partner to Advance Institutional Infrastructure for Tokenized Securities
September 11, 2026
-
Hypercharge Enters into Letter of Intent to Acquire REVS Charging LLC
September 11, 2026
-
Top News
- NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical’s FDA-Cleared Robotic TMS System September 11, 2026
- CPI Announces Pricing of Secondary Public Offering of Common Stock September 11, 2026
- Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement September 11, 2026
- Beamr to Present at the H.C. Wainwright 28th Annual Global Investment Conference September 11, 2026
Axe Compute (NASDAQ AGPU) 2026 Q2 Earnings Call
Watch the replay of Axe Compute's Second Quarter 2026 earnings conference call, originally held live on Monday, August 17, 2026 at 8:30 a.m. Eastern Time. Christopher Miglino, Chief Executive Officer; Kyle Okamoto, President; and Jeremy Yaukey-Witter, Chief Financial Officer, review the Company's Q2 2026 financial results, recent business developments, and priorities for the second half of 2026. Key highlights discussed on the call: Revenue grew more than 90x sequentially in the Company's first full quarter of compute operations Customer prepayments grew from $0.8 million to $60.8 million, with $17.4 million in operating cash flow in the first half of 2026 The $260 million dedicated cluster of 2,304 NVIDIA B300 GPUs progressed through build, targeted for Q3 2026 go-live Total 2026 signed contracted value now exceeds $3 billion Read the full press release and financial statements on Axe Compute's investor website.
August 17, 2026Popular Reads
-
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
TARPON SPRINGS, Fla., September 11, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated dual PARP/Wnt pathway inhibitor using its proprietary DRP® technology, announced that Allarity Acquisition Corp., a newly formed special purpose acquisition company (SPAC), has publicly filed a Registration Statement on […]
September 11, 2026
-
Asure’s 2026 HR Benchmark Report Finds Compliance Confidence Collapsing at America’s Small Businesses
AUSTIN, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) — Asure Software, Inc. (Nasdaq: ASUR), a provider of payroll and HR solutions for employers and enterprise payroll tax and treasury infrastructure, released its 2026 HR Benchmark Report at its annual Asure50 Awards event, finding that small-business owners have lost confidence they are complying with employment law. Among […]
September 9, 2026
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical’s FDA-Cleared Robotic TMS System
HOPE is the first Interventional Psychiatry network to deploy Zeta Surgical’s newly FDA-cleared TMS Robotic System; the HOPE clinical team is completing orientation and training at Zeta Surgical’s headquarters in Boston ahead of deployment in HOPE’s Florida clinics The Zeta TMS Robotic System’s AI-driven software adjusts the TMS coil in real time with submillimeter precision, […]
September 11, 2026
-
Nuvve Launches AI-Powered Forecasting Platform to Optimize Battery Value and Grid Resiliency
Proprietary AI technology combines energy market, weather, grid, policy and other signals to forecast energy prices and load, helping battery operators and utilities make more informed decisions SAN DIEGO, September 09, 2026–(BUSINESS WIRE)–Nuvve Holding Corp. (“Nuvve” or the “Company”) (OTCQB Market: NVVE), a global leader in intelligent energy management and Vehicle-to-Grid (V2G) technology, today launched […]
September 9, 2026
News
-
Today’s Stock Market in 2-Minutes
September 11, 2026
-
The $900 Billion Data Center Boom Is Just Getting Started
September 11, 2026
-
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
September 11, 2026
-
Glucotrack Announces $11.5 Million Financing
September 11, 2026
-
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
September 11, 2026
-
Polymath and High Ridge Trust Partner to Advance Institutional Infrastructure for Tokenized Securities
September 11, 2026
-
CNB Community Bancorp, Inc. Declares Quarterly Cash Dividend of $0.34 Per Share
September 11, 2026
-
CPI Announces Pricing of Secondary Public Offering of Common Stock
September 11, 2026